GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (OTCPK:SSMXF) » Definitions » Cash per Share

Sysmex (Sysmex) Cash per Share : $0.82 (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sysmex Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Sysmex's Cash per Share for the quarter that ended in Mar. 2024 was $0.82.


Sysmex Cash per Share Historical Data

The historical data trend for Sysmex's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex Cash per Share Chart

Sysmex Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.99 1.01 0.84 0.82

Sysmex Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.84 0.72 0.75 0.68 0.82

Sysmex Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Sysmex's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Sysmex's Cash per Share for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sysmex  (OTCPK:SSMXF) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Sysmex Cash per Share Related Terms

Thank you for viewing the detailed overview of Sysmex's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (Sysmex) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (Sysmex) Headlines

From GuruFocus

Matthews Japan Fund Comments on Sysmex

By Vera Yuan Vera Yuan 02-05-2015

Matthews Japan Fund Comments on Sysmex

By Sydnee Gatewood Sydnee Gatewood 10-21-2020

Matthews Japan Fund Q4 2014 Commentary

By Vera Yuan Vera Yuan 02-05-2015

Vanguard Health Care Fund Gains 4 International Stocks in 2nd Quarter

By Sydnee Gatewood Sydnee Gatewood 08-04-2017